英文别名Cabozantinib impurity DYH; 1-N-[4-(6,7-dimethoxy-1-oxidoquinolin-1-ium-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; Cabozantinib metabolite M19; EXEL-5162; 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropanecarboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide; 4-[4-[1-[(4-Fluorophenyl)carbamoyl]cyclopropanecarboxamido]phenoxy]-6,7-dimethoxyquinoline 1-Oxide; Cabozantinib Impurity 04 
